mesalamine 66.7 MG/ML Enema

Known as: mesalazine 66.7 MG/ML Enema, Mesalamine KIT, mesalamine 4 GM per 60 ML Enema 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2018
01220092018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Background Disease activity of patients with ulcerative colitis (UC) predicts health-related quality of life (HRQL) and work… (More)
Is this relevant?
Review
2018
Review
2018
Background: Ulcerative colitis (UC) is associated with lower health-related quality of life (HRQoL), and with disease activity… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2016
2016
BACKGROUND Limited data are available on mesalamine (5-aminosalicylic acid; 5-ASA) use in pediatric ulcerative colitis (UC… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2009
2009
BACKGROUND Many patients with ulcerative colitis (UC) respond to mesalamine therapy within 8 weeks. Those not achieving remission… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?